UBS Maintains a 'Neutral' on Life Time Fitness (LTM); Powering Ahead
Get Alerts LTM Hot Sheet
Price: $51.39 --0%
Rating Summary:
10 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
10 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
UBS maintains a 'Neutral' on Life Time Fitness (NYSE: LTM) price target of $41.00.
UBS analyst says, "LTM’s reported 3Q’11 results were strong on many metrics: LTM reported EPS of $0.67, which was in-line with our estimate of $0.67 but above the consensus of $0.65. LTM experienced accelerating metrics in average revenue per member, attrition reduction, 2-year stacked same-center revenue growth, and dues revenue growth, while also experiencing positive growth in other key drivers in a tough economic environment." (UBS raises FY11 EPS estimate from $2.33 to $2.37, but slightly lowers FY12 from $2.59 to $2.56)
For more ratings news on Life Time Fitness click here and for the rating history of Life Time Fitness click here.
Shares of Life Time Fitness closed at $40.67 yesterday.
UBS analyst says, "LTM’s reported 3Q’11 results were strong on many metrics: LTM reported EPS of $0.67, which was in-line with our estimate of $0.67 but above the consensus of $0.65. LTM experienced accelerating metrics in average revenue per member, attrition reduction, 2-year stacked same-center revenue growth, and dues revenue growth, while also experiencing positive growth in other key drivers in a tough economic environment." (UBS raises FY11 EPS estimate from $2.33 to $2.37, but slightly lowers FY12 from $2.59 to $2.56)
For more ratings news on Life Time Fitness click here and for the rating history of Life Time Fitness click here.
Shares of Life Time Fitness closed at $40.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Bros. (TOL) PT Raised to $195 at UBS on Stronger Margin Expectations
- Deutsche Bank Upgrades Target Hospitality (TH) to Buy
- BofA Securities Starts ProQR Therapeutics N.V. (PRQR) at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share